Wells Fargo & Company Ionis Pharmaceuticals Inc Transaction History

Wells Fargo & Company

$433 Billion
Q4 2024

A detailed history of Wells Fargo & Company transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Wells Fargo & Company holds 331,009 shares of IONS stock, worth $10.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

331,009

Previous 342,154 3.26%

Holding current value

$10.3 Million

Previous $13.7 Million 15.57%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$33.73 - $40.36 $375,920 - $449,812	-11,145 Reduced 3.26%	331,009 $11.6 Million
Q3 2024 Nov 13, 2024	SELL	$40.06 - $51.86 $977,744 - $1.27 Million	-24,407 Reduced 6.66%	342,154 $13.7 Million
Q2 2024 Aug 13, 2024	SELL	$36.45 - $47.7 $7.93 Million - $10.4 Million	-217,597 Reduced 37.25%	366,561 $17.5 Million
Q1 2024 May 10, 2024	SELL	$42.03 - $53.55 $424,166 - $540,426	-10,092 Reduced 1.7%	584,158 $25.3 Million
Q4 2023 Feb 09, 2024	SELL	$43.39 - $51.63 $1.03 Million - $1.22 Million	-23,680 Reduced 3.83%	594,250 $30.1 Million
Q3 2023 Nov 13, 2023	BUY	$38.5 - $47.13 $194,001 - $237,488	5,039 Added 0.82%	617,930 $28 Million
Q2 2023 Aug 15, 2023	SELL	$34.73 - $43.33 $460,485 - $574,512	-13,259 Reduced 2.12%	612,891 $25.1 Million
Q1 2023 May 12, 2023	BUY	$33.58 - $41.2 $608,133 - $746,132	18,110 Added 2.98%	626,150 $22.4 Million
Q4 2022 Feb 13, 2023	SELL	$37.12 - $46.52 $3.04 Million - $3.81 Million	-81,832 Reduced 11.86%	608,040 $23 Million
Q3 2022 Nov 14, 2022	SELL	$36.54 - $48.66 $1.25 Million - $1.66 Million	-34,123 Reduced 4.71%	689,872 $30.5 Million
Q2 2022 Aug 12, 2022	SELL	$31.71 - $43.0 $3.75 Million - $5.09 Million	-118,289 Reduced 14.04%	723,995 $26.8 Million
Q1 2022 May 16, 2022	BUY	$29.88 - $37.04 $935,781 - $1.16 Million	31,318 Added 3.86%	842,284 $31.2 Million
Q4 2021 Feb 14, 2022	SELL	$25.61 - $35.1 $1.09 Million - $1.49 Million	-42,404 Reduced 4.97%	810,966 $24.7 Million
Q3 2021 Nov 15, 2021	BUY	$33.54 - $40.55 $400,434 - $484,126	11,939 Added 1.42%	853,370 $28.6 Million
Q2 2021 Aug 16, 2021	SELL	$34.54 - $47.25 $10.9 Million - $14.9 Million	-315,568 Reduced 27.27%	841,431 $33.6 Million
Q1 2021 May 13, 2021	BUY	$42.51 - $63.78 $267,005 - $400,602	6,281 Added 0.55%	1,156,999 $52 Million
Q4 2020 Feb 09, 2021	BUY	$45.3 - $60.27 $10.5 Million - $14 Million	232,691 Added 25.35%	1,150,718 $65.1 Million
Q3 2020 Nov 05, 2020	SELL	$47.45 - $62.95 $2.35 Million - $3.11 Million	-49,422 Reduced 5.11%	918,027 $43.6 Million
Q2 2020 Aug 13, 2020	BUY	$46.85 - $61.05 $7,308 - $9,523	156 Added 0.02%	967,449 $57 Million
Q1 2020 May 14, 2020	BUY	$41.6 - $63.4 $40.2 Million - $61.3 Million	967,293 New	967,293 $45.7 Million

Others Institutions Holding IONS

# of Institutions

416

Shares Held

140M

Call Options Held

861K

Put Options Held

714K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.41B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Ionis Pharmaceuticals Inc Transaction History